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Techniques for Electrophysiological and
Device Implantation Procedures
Angelo Auricchio, MD, PHD, Francesco Fulvio Faletra, MD
ABSTRACT
Recent technological advances in cardiac imaging allow the visualization of anatomic details up to millimeter size in
3-dimensional format. Thus, it is not surprising that electrophysiologists increasingly rely upon cardiac imaging for the
diagnosis, treatment, and subsequent management of patients affected by various arrhythmic disorders. Cardiac imaging
methods reviewed in the present work involve: 1) the prediction of arrhythmic risk for sudden cardiac death in patients
with heart disease; 2) catheter ablation of atrial ﬁbrillation or ventricular tachycardia; and 3) cardiac resynchronization
therapy. Future integration of diagnostic and interventional cardiac imaging will further increase the effectiveness of
cardiac electrophysiological procedures and will help in delivering patient-speciﬁc therapies with ablation and cardiac
implantable electronic devices. (J Am Coll Cardiol Img 2019;-:-–-) © 2019 The Authors. Published by Elsevier on
behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
O ver the past 2 decades, impressive techno-logical advances in cardiac imaging haveoccurred that allow the visualization
of anatomic details up to millimeter size in
3-dimensional (3D) format and assessment of myocar-
dial deformation with unprecedented time resolution.
Thus, it is not surprising that electrophysiologists
have increasingly relied upon cardiac imaging for the
diagnosis, treatment, and subsequent management
of patients affected by various arrhythmic disorders.
In this review (Central Illustration), we consider
selected arrhythmic disorders for which contempo-
rary cardiac imaging technology is integral to diag-
nostic and follow-up workﬂow: 1) prediction of
arrhythmic risk for sudden cardiac death in selected
patient populations; 2) catheter ablation of arrhyth-
mias; and 3) cardiac resynchronization therapy (CRT).
CARDIOVASCULAR IMAGING IN THE
PREDICTION OF ARRHYTHMIC RISK FOR
SUDDEN CARDIAC DEATH IN SELECTED
PATIENT POPULATIONS
Risk assessment of ventricular arrhythmias is of
paramount importance in patients with heart disease.
Although a recent meta-analysis documented that the
rate of sudden cardiac death declined substantially
among ambulatory patients with heart failure (HF)
and reduced left ventricular ejection fraction (LVEF)
(1), sudden cardiac death still represents a major
cause of cardiovascular death. Current guidelines for
the use of implantable cardioverter-deﬁbrillators
(ICDs) in primary prevention are based mostly on
LVEF values (2,3), despite the fact that this parameter
is considered an unsatisfactory risk marker for
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sudden cardiac death. Indeed, a severely
depressed LVEF is a low-speciﬁcity marker in
differentiating risk for sudden cardiac death
from risk for death associated with comor-
bidities or with the evolution of HF. Simi-
larly, sudden cardiac death can occur in
patients with normal or mildly depressed
LVEFs. Therefore, abnormal myocardial
structure (substrate) rather than volumetric
and functional assessment is becoming the
new reference for the evaluation of sudden
cardiac death risk. Although sudden cardiac
death in patients with prior myocardial
infarction is attributed mainly to the result of
re-entrant ventricular arrhythmias origi-
nating from surviving myocardial strain
embedded into infarcted myocardium
(Figure 1), the mechanism in nonischemic
cardiomyopathy is less well understood but
possibly related to ﬁbrosis. Although multi-
ple imaging modalities can be used to ascer-
tain myocardial scar and ﬁbrosis, cardiac
magnetic resonance (CMR) late gadolinium enhance-
ment (LGE) holds the greatest promise for noninva-
sive risk assessment of ventricular arrhythmias. LGE
by CMR has recently become a widely available clin-
ical diagnostic procedure to visualize in vivo
myocardial scar and ﬁbrosis in patients with a variety
of myocardial diseases and has emerged as the gold
standard for identifying myocardial ﬁbrosis.
Furthermore, the recent addition of high-resolution
LGE imaging to the CMR protocol has signiﬁcantly
improved the performance of CMR in detecting small
left ventricular (LV) or right ventricular substrates,
particularly in patients without structural heart dis-
ease as diagnosed on transthoracic echocardiography
or coronary angiography (4).
RISK ASSESSMENT IN PATIENTS WITH ISCHEMIC
AND NONISCHEMIC CARDIOMYOPATHY BY CMR.
In a recent meta-analysis, Disertori et al. (3) evaluated
the predictive value of LGE for ventricular tachyar-
rhythmia in patients with ischemic and nonischemic
cardiomyopathy with ventricular dysfunction,
including 2,850 patients collected from 19 different
studies with a mean follow-up time of 2.8 years. The
investigators demonstrated that LGE represents a
powerful predictor of ventricular tachyarrhythmia
events in patients with ventricular dysfunction of
ischemic and nonischemic etiology (Figures 1 and 2).
The composite arrhythmic endpoint was reached in
23.9% of patients with positive results on LGE testing
(annualized event rate 8.6%) compared with 4.9% of
patients with negative results (annualized event rate
1.7%) (p < 0.0001). LGE correlated with arrhythmic
events in the different patient groups. In the overall
population, the pooled odds ratio was 5.62 (95%
conﬁdence interval [CI]: 4.20 to 7.51), with no sig-
niﬁcant differences between ischemic and non-
ischemic patients. In a subgroup of 11 studies
(n ¼ 1,178) with mean LVEF #30%, the pooled odds
ratio for the arrhythmic events increased to 9.56
(95% CI: 5.63 to 16.23), with a negative likelihood ratio
of 0.13 (95% CI: 0.06 to 0.30). Notably, the odds ratio
was almost doubled in studies with mean
LVEFs #30% compared with >30%, thus indicating
that the prognostic power of LGE for ventricular ar-
rhythmias is particularly strong in patients with
severely depressed LVEFs. In addition, it indicates
that even in a challenging group of patients such as
those with LVEFs >30%, LGE can be used as a reliable
marker for predicting arrhythmic events. The impor-
tance of evaluating LGE in patients with nonischemic
cardiomyopathy has become relevant following the
recent ﬁndings of DANISH (Danish Study to Assess
the Efﬁcacy of ICDs in Patients With Non-Ischemic
Systolic Heart Failure on Mortality) (5), which
showed no reduction in overall mortality among pa-
tients with nonischemic cardiomyopathy with high
rates of guideline-recommended pharmacological
therapy. More recently, Leyva et al. (6) studied non-
ischemic cardiomyopathy CRT patients with midwall
ﬁbrosis (n ¼ 68) compared with those without mid-
wall ﬁbrosis (n ¼ 184). They showed that CRT with a
deﬁbrillator was superior to CRT only in patients with
midwall ﬁbrosis (Figure 2); however, a large pro-
spectively designed controlled trial is needed to
conﬁrm these ﬁndings.
Advanced LGE post-processing techniques have
been recently developed to better quantify myocar-
dial scar tissue and to differentiate between scar core
and border zone. The border zone extension and scar
heterogeneity have been associated with inducibility
of ventricular tachyarrhythmias and mortality pre-
diction in patients with structural heart disease. This
hypothesis was recently tested in the GAUDI-CRT
(Life-Threatening Arrhythmic Events and Sudden
Cardiac Death in Cardiac Resynchronization Therapy
Patients) trial, which included 217 CRT patients (7).
Pre-procedural LGE was obtained and analyzed to
identify scar presence or absence, to quantify the
amount of core and border zone, and to depict border
zone distribution. During a median follow-up period
of 35.5 months, appropriate ICD therapy or sudden
cardiac death occurred in 25 patients (11.5%) and did
not occur in CRT patients without myocardial scar.
Among patients with scar (n ¼ 125 [57.6%]), those
with ICD therapies or sudden cardiac death exhibited
ABBR EV I A T I ON S
AND ACRONYMS
3D = 3-dimensional
AF = atrial ﬁbrillation
CI = conﬁdence interval
CRT = cardiac
resynchronization therapy
CMR = cardiac magnetic
resonance
HF = heart failure
ICD = implantable
cardioverter-deﬁbrillator
LA = left atrial
LV = left ventricular
LVEF = left ventricular ejection
fraction
LGE = late gadolinium
enhancement
MVP = mitral valve prolapse
PVI = pulmonary vein isolation
VT = ventricular tachycardia
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greater scar mass (38.7  34.2 g vs. 17.9  17.2 g;
p < 0.001), scar heterogeneity (border zone mass/scar
mass ratio 49.5  13.0 vs. 40.1  21.7; p ¼ 0.044), and
border zone channel mass (3.6  3 g vs. 1.8  3.4 g;
p ¼ 0.018). Border zone mass and channel mass were
the strongest predictors of arrhythmic events. An
automated algorithm based on scar mass and absence
of border zone channels identiﬁed 68.2% (n ¼ 148)
without ICD therapy or sudden cardiac death during
follow-up with 100% negative predictive value
CENTRAL ILLUSTRATION Use of Contemporary Imaging Techniques for Electrophysiological and
Device Implantation Procedures
Auricchio, A. et al. J Am Coll Cardiol Img. 2019;-(-):-–-.
See Figures 1 to 3 and 6 to 8 for details.
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(Figure 3, Video 1). Although the ﬁndings of this study
require conﬁrmation in larger and properly designed
clinical trials, especially for the ICD population, they
are extremely promising, as they indicate the possi-
bility to accurately stratify risk in patients with HF on
the basis of morphological and anatomic characteris-
tics. Interestingly, Haugaa et al. (8) hypothesized that
in patients after myocardial infarction, mechanical
dispersion, as assessed by longitudinal strain speckle-
tracking echocardiography, may be correlated with
scar heterogeneity and therefore with risk for ar-
rhythmias. In each patient, the investigators deﬁned
mechanical dispersion as the standard deviation of 16
different time intervals to maximum myocardial
deformation. They found that mechanical dispersion
was greater in ICD patients with recorded ventricular
arrhythmias compared with those without (85 
29 ms vs. 56  13 ms; p < 0.001). By Cox regression,
mechanical dispersion was a strong and independent
predictor of arrhythmias requiring ICD therapy (haz-
ard ratio: 1.25 per 10-ms increase; 95% CI: 1.1 to 1.4;
p < 0.001) (8).
RISK ASSESSMENT IN PATIENTS WITH MITRAL
VALVE PROLAPSE. Degenerative mitral valve pro-
lapse (MVP) is the most frequent cause of primary
mitral regurgitation in Western countries, affecting
1% to 3% of the general population (9). A small but
notable proportion of patients with MVP may develop
malignant arrhythmias and sudden cardiac death
(10); the estimated rate of sudden cardiac death
attributed to ventricular ﬁbrillation in patients with
primary MVP remains exceedingly low (0.2% to 0.4%
per year) (11). Several morphological aspects, such as
bileaﬂet MVP with diffuse leaﬂet redundancy and
thickening (due to accumulation of proteoglycans
through the spongiosa), chordae elongation, and
annular dilation, electrocardiographic abnormalities,
severity of mitral valve regurgitation, and LV
dysfunction have been associated with arrhythmias
in MVP (12). An anatomic substrate for promoting
electric instability was described by Sanﬁlippo et al.
(13) and subsequently by Han et al. (14). These in-
vestigators demonstrated the presence of LGE on
valve leaﬂets (indicating the expansion of spongiosa
due to proteoglycans accumulations) and on the tips
of papillary muscles (indicating ﬁbrosis). Interest-
ingly, the presence of ﬁbrosis at the papillary muscles
tip was more often observed in a subgroup of patients
with arrhythmic MVP. More recently, Basso et al. (15)
conﬁrmed and extended these observations. In 43
young patients (age range 10 to 40 years) with
MVP and myxomatous valve who died of sudden
cardiac death, the investigators found patches of
FIGURE 1 Late Gadolinium Enhancement in a Previous Inferior-Posterior Myocardial Infarction
A
Ao
LA
LV
B
(A) Long-axis view showing an extensive scar on the posterior wall (white area) as a result of a previous inferior-posterior myocardial
infarction. (B)Magniﬁed image of the apical portion of the posterior wall (white square in A), presenting the border zone of inferior-posterior
myocardial infarction and 2 layers of normal myocardium (white arrows) surrounding 1 layer of scar (red arrow). This particular substrate may
trigger ventricular tachyarrhythmias. Ao ¼ aorta; LA ¼ left atrium; LV ¼ left ventricle.
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replacement-type ﬁbrosis on papillary muscles and
on subendocardial-midmural layers of basal posterior
wall, just below the posterior valve leaﬂet (Figure 4,
Videos 2 and 3). They hypothesized that systolic
mechanical stretch of myocardium closed to the
mitral valve might have accounted for injuries,
eventually leading to replacement-type ﬁbrosis.
Marra et al. (16) provided further evidence for this
hypothesis, ﬁnding that mitral annular disjunction,
deﬁned as a separation between the left atrial (LA)
wall–mitral hinge line and the LV free wall, is a con-
stant feature in patients with arrhythmic MVP
(Figure 4). They hypothesized that this peculiar
morphological aspect might contribute to the systolic
stretch of the myocardium close to the valve and, as a
result, to the propensity to develop regional LV
ﬁbrosis and electric instability. According to their
conclusions, the genesis of malignant arrhythmias in
MVP may be recognized in the deadly combination of
a substrate (papillary muscle tips and basal free wall
myocardial ﬁbrosis) and a trigger (i.e., myocardial
stretch exacerbated by mitral annular dysfunction)
(Figure 5).
CARDIOVASCULAR IMAGING IN
CATHETER ABLATION OF ARRHYTHMIAS
ATRIAL FIBRILLATION. The link between atrial
ﬁbrosis and atrial ﬁbrillation (AF) onset and progres-
sion is well known, and the possibility to visualize
atrial ﬁbrosis by CMR has presented unprecedented
diagnostic and interventional opportunities. Conse-
quently, pre-procedural assessment of atrial ﬁbrosis
to screen out patients undergoing pulmonary
vein ablation may signiﬁcantly help in improving the
cost/beneﬁt and risk/effectiveness ratios of catheter
ablation in patients with AF. Likewise, visualization
of ﬁbrosis area and integration into 3D mapping
FIGURE 2 Midwall Fibrosis Evaluation
A
Ao
LA LA
RA
RV
RV RV
LV
LV LV
LV
B
C D
Midwall ﬁbrosis as detected with late gadolinium enhancement in a patient with nonischemic cardiomyopathy in (A) 4-chamber, (B) long-axis,
and (C,D) short-axis views. AO ¼ aorta; LA ¼ left atrium; LV ¼ left ventricle; RA ¼ right atrium; RV ¼ right ventricle.
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systems to guide AF catheter ablation strategy (e.g.,
pulmonary vein isolation [PVI] or additional lines)
may improve outcomes in patients undergoing cath-
eter ablation. LGE on CMR can detect ablated regions,
together with the evolution of their pattern and signal
intensity over time, likely suggesting initial edema
followed by scar formation; this possibility may
further help in the management of those patients
presenting with AF recurrence. Finally, visualization
of ﬁbrosis and inclusion in computer modeling is the
next frontier in cardiac electrophysiology to develop
patient-speciﬁc ablation strategy.
The DECAAF study by Marrouche et al. (17) was the
ﬁrst multicenter, prospective, observational cohort
study of patients diagnosed with paroxysmal and
persistent AF undergoing their ﬁrst catheter ablation
with PVI. CMR imaging was performed before abla-
tion, and atrial ﬁbrosis was quantiﬁed and classiﬁed
into stages: 1 (<10% of the atrial wall); 2 ($10%
to <20%); 3 ($20% to <30%); and 4 ($30%). The cu-
mulative incidence of recurrent arrhythmia at 1 year
for stages 1, 2, 3, and 4 was 15.3%, 32.6%, 45.9%, and
51.1%, respectively. This and several subsequent
studies emphasize the importance of baseline imag-
ing and quantiﬁcation of atrial scar as a key predictor
of procedural outcomes after PVI. Altogether, these
studies are precursors to further investigations of
substrate modiﬁcation in addition to PVI, speciﬁcally
in patients with severe atrial scarring as detected by
CMR. Recent observations regarding the use of CMR
for ﬁbrosis imaging are, however, conﬂicting. A pro-
spective single-center experience of 149 consecutive
patients (64 persistent, 85 paroxysmal) undergoing
AF ablation showed that delayed enhancement
detected by CMR within the LA walls using standard
clinical scanners and typical pulse sequence param-
eters was uncommon (n ¼ 5, prevalence 3%) and,
when present, did not correlate with AF type or risk
for AF recurrence (18). These results clearly conﬂict
with other investigational data (19). As suggested by
Pontecorboli et al. (20) in a recent review, it is clear
that ﬁbrosis and scar detection by CMR is not without
pitfalls. Indeed, the development of standardized
speciﬁc protocols and uniform cutoffs for ﬁbrosis
detection may lead to improved accuracy and repro-
ducibility (Figure 6). Furthermore, relative atrial wall
thickness (which is similar to the spatial resolution of
CMR) represents a signiﬁcant anatomic challenge in
the 3D volumetric estimation of ﬁbrosis and scar by
this imaging technique. This becomes highly relevant
when considering the experimental evidence that in
the early stage of the disease, the ﬁbrosis is mostly
FIGURE 3 Three-Dimensional Color-Coded Signal Intensity Maps
The signal intensity maps in 5 transmural shells were obtained with speciﬁc cardiac magnetic resonance sequences representing the scar,
shape, and distribution of the scar tissue across the wall thickness. Purple represents normal tissue, green the border zone, and red scar
tissue. Channels, possible ablation targets, are indicated as well (see also Video 1).
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conﬁned to the epicardial layers and progressively
expands transmurally. Finally, although most of the
studies have focused on ﬁbrosis and scar assessment
in the left atrium, structural changes have remained
nearly unexplored in the right atrium, a cardiac
chamber that is now becoming an ablation target in
non-PVI-dependent AF. Outcomes among patients
with persistent AF after PVI are still a matter of
considerable debate. Although some may beneﬁt
from ablation, in others, sinus rhythm cannot be
maintained for a reasonable amount of time despite
extensive ablation (21). Parwani et al. (22) found that
LA strain is lower in patients with recurrence of atrial
arrhythmias after PVI (n ¼ 55) than those without
recurrence (LA strain 9.7  2.4% vs. 16.2  3.0%;
p < 0.001), concluding that low (<10%) LA strain
predicts recurrence of AF (hazard ratio: 6.4; 95% CI:
2.4 to 16.9; p < 0.001). This ﬁnding strongly suggests
a profound link between electric and mechanical
function, a research area that has not received sufﬁ-
cient attention.
VENTRICULAR TACHYCARDIA. Over the past 2 de-
cades, the role of cardiac imaging in patients with
ventricular tachycardia (VT) has progressed from
making relatively crude measurements of LVEF to
deﬁning intricate details of scar architecture and,
perhaps most important, providing complementary
information on electric activation. This latter
approach was extensively covered in a recent review
by Mahida et al. (23). Electrophysiological substrate
mapping during sinus or paced rhythm allows the
characterization of scar areas to identify so-called
conducting channels, the electrophysiological basis
for re-entry circuits of VT. These channels can be
identiﬁed by intracardiac voltage mapping or elec-
trogram analysis and are considered the ablation
target. Radiofrequency applications at the conducting
channels entrance (the so-called scar dechanneling
technique) can homogenize the scar without exten-
sive ablation and could possibly increase the ablation
efﬁciency (Figures 3 and 7). High-resolution contrast-
enhanced CMR accurately delineates the scar and
makes it possible to differentiate between scar core
and border zone and, together with advanced post-
processing, to allow the visualization of the border
areas inside the scar as corridors of viable tissue
connecting the healthy myocardium (24). These
FIGURE 4 Cine Cardiac Magnetic Resonance Showing a Mitral Valve Disjunction in a Patient With Mitral Valve Prolapse
A
IVS
B
C D
E F
G HAtrio-
valvular
junction
Atrio-valvular
junction
atrio-
valvar
junction
Atrial-
ventricular
junction
Atrial-
ventricular
junction
The area in the red box is magniﬁed in B. The image clearly shows that the hinge of the posterior mitral leaﬂet is attached to the atrial wall. forming the
atriovalvular junction, while the crest of interventricular septum (IVS) is far from the mitral hinge line. (C) Two-dimensional and (E) 3-dimensional transesophageal
echocardiography showing the same patient as in (A). The areas in the red boxes are magniﬁed in D and F, respectively. This peculiar morphology is thought to
contribute to the systolic stretch of the basal posterior myocardial wall and tips of papillary muscles developing regional left ventricular ﬁbrosis (arrows) and electric
instability (see Videos 2 and 3).
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corridors correlate with the conducting channels on
electroanatomic mapping. CMR-based visualization
of scar characteristics is helpful in VT ablation pro-
cedures (Figures 3 and 7) (25). As recently reported by
Andreu et al. (26), the ablation strategy of scar
dechanneling alone results in lower recurrence and
mortality rates in more than one-half of patients,
despite the required limited ablation extent
compared with a more traditional ablation approach.
The investigators compared the outcomes of 54 pa-
tients (34%) who had pixel signal intensity maps were
obtained from a high-resolution 3-T LGE CMR study
and imported into the navigation system to aid in VT
substrate ablation, with those of the remaining 105
patients, who had pixel signal intensity maps could
either be obtained or be imported into the navigation
system. The use of pixel signal intensity maps to
guide the ablation minimized the number of radio-
frequency applications and ablation delivery time
needed. This was also associated with a higher rate of
immediate success after substrate ablation, thus
suggesting better identiﬁcation of the arrhythmo-
genic substrate and target ablation site. Notably, the
information obtained from CMR, showing the wall
distribution of the scar, contributed to the decision on
the optimal approach (endocardial, epicardial, or
combined), which could explain the reported better
outcomes in the CMR-aided group compared with the
other patients. However, pixel signal intensity alone
was not sufﬁcient in achieving the best outcome, as
the integration of the pixel signal intensity map into
the navigation system actually made the difference.
This ﬁnding indicates that a holistic “anatomic and
electroanatomic” approach is the key because it
FIGURE 5 3-Dimensional Transesophageal Echocardiographic View From Overhead Showing a Patient With Barlow Disease
A
AO
AOMAD
AO
AO
Atrio-
valvular
junction
Atrio-
valvular
junction
Ventriculo-
atrial
junctionVentriculo-atrial
junction
B
C D
From this perspective, the mitral-aortic disjunction (MAD) is not visible. A crop in the direction of the thick arrow up to the center of the valve (dotted line) (A) leads to
half valve (B). A progressive rotation (curved arrow) around the x-axis (C,D) reveals the MAD as the rectangular space between the atriovalvular junction and the
ventricular-atrial junction. AO ¼ aorta.
Auricchio and Faletra J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . - , N O . - , 2 0 1 9
Imaging in Electrophysiology and Device Implantation - 2 0 1 9 :- –-
8
allows a complete identiﬁcation of the arrhythmo-
genic substrate, an improved selection of the ven-
tricular area to focus mapping, and ﬁnally better
localization of the target ablation site (i.e., the con-
ducting channel entrances).
CARDIOVASCULAR IMAGING IN CRT
Although CRT has been used for more than 2 decades,
the proportion of patients who do not respond has
remained nearly static (30% to 50%) over a period of
extensive technological and technical development
(27). Suboptimal response to CRT is multifactorial and
may include suboptimal lead placement, ineffective
delivery of biventricular pacing, and inappropriate
selection of atrioventricular and interventricular
delay (28). Moreover, an increasing number of clinical
studies has demonstrated the importance of avoiding
areas of myocardial ﬁbrosis and targeting regions of
latest mechanical activation. TARGET (Targeted Left
Ventricular Lead Placement to Guide Cardiac
Resynchronization Therapy) and STARTER (Speckle
Tracking Assisted Resynchronization Therapy for
Electrode Region) were both randomized controlled
studies evaluating the use of speckle-tracking
echocardiography for pre-procedural targeting of
myocardial segments for LV lead delivery, compared
with conventional non-image-guided implantation
(29,30). Consistently, both studies showed that
patients in which LV leads were placed in a region of
latest mechanical activation had signiﬁcantly reduced
rates of HF hospitalization and death compared with
those who had leads were placed otherwise. A large
retrospective registry of 559 patients who had pre-
procedural CMR was performed demonstrated that
patients with LV leads implanted in areas of
myocardial ﬁbrosis had a greater hazard ratio for
cardiovascular death or HF hospitalization compared
with those who had the leads were out of scar (31).
More recently, a selection of multimodality imag-
ing studies has shown the additional beneﬁt for
avoiding scar and targeting dyssynchrony among
patients being treated with CRT (32,33). A common
theme among these studies is the observed
improvement in CRT response rate (approximately
15% to 20%) in patients implanted using image-
guided approaches. Although the results from the
growing number of image guidance studies are
encouraging, 1 of the major limitations is that the data
output in each study is analyzed separately from
radiography, rather than being integrated together.
The variability in the rotation of the left- and right-
sided chambers relative to each other, however,
hinders the determination of regional anatomy with
regard to lead position. Behar et al. (34,35) have
recently published the ﬁrst clinical study to evaluate
a platform that enables the real-time analysis and
fusion of CMR-derived scar and dyssynchrony data to
FIGURE 6 Methods to Discriminate Left Atrial Fibrosis in Magnetic Resonance Imaging With Late Gadolinium Enhancement: Thresholding Techniques
Pixel Intensity
Signal Intensity
N·SD 
+2 SD +3 SD +4 SD
Mean
2–40%
4 SD
Fibrosis: 0.4%
3 SD
Fibrosis: 3.18%
2 SD
Fibrosis: 17.95%
IIR
Fibrosis: 39.38%
Dense fibrosis: 0%
Bimodal distribution of pixel intensities of the left atrial (LA) wall. “Normal tissue” is deﬁned as the ﬁrst mode of lower pixel intensities and “injured tissue” at n standard
deviations (SDs) above the mean pixel intensity of normal tissue, and histogram of pixel intensities: “normal” tissue is deﬁned as the lower region of the pixel intensity
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with permission from Pontecorboli et al. (20).
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FIGURE 8 Target Delivery of Cardiac Resynchronization Therapy
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Image panel of workﬂow for real-time cardiac magnetic resonance–guided left ventricular lead implantation for targeted delivery of cardiac resynchronization therapy
(CRT). Reproduced with permission from Behar et al. (34). 3D ¼ 3-dimensional; CMR ¼ cardiac magnetic resonance.
FIGURE 7 Example of Multimodal Image Integration to Facilitate Treatment Strategies
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Pre-procedural late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) shows scar channels (SCs) and border zone (BZ), whereas computed to-
mography (CT) shows coronary arteries and epicardial fat thickness. Both images are integrated in a mapping system in which normal voltage areas are depicted in
purple for catheter ablation (scar dechanneling). Modiﬁed with permission from Sramko et al. (25). 3D ¼ 3-dimensional; EAM ¼ electroanatomic mapping.
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FIGURE 9 Simulated Substrates of Mechanical Discoordination, Created by the CircAdapt Model
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Different myocardial substrates and corresponding regional strain developments in electric hypocontractile substrate or in a nonelectric hypocontractile
substrate were simulated. Reproduced with permission from Lumens et al. (39). AVC ¼ aortic valve closure; AVO ¼ aortic valve opening; LBBB ¼ left
bundle branch block; LV ¼ left ventricle; RV ¼ right ventricle.
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guide LV lead implantation. Upon completion of a
routine CMR scan, the patient is transferred to the
adjacent catheter laboratory while the imaging data-
set is processed within 25 min. Segmentation of long-
and short-axis CMR sequences generates a 3D mesh
along with a detailed location, burden, and trans-
murality of myocardial ﬁbrosis. This process allows
the identiﬁcation of regions with the greatest dys-
synchrony (Figure 8). Following a short registration
step of the 3D model to the radiographic coordinate
system, any subsequent radiographic acquisition is
displayed with instantaneous overlay of the correctly
oriented 3D model. Upon coronary venography, the
3D-derived model of the patient’s left ventricle is
instantaneously fused, thus enabling identiﬁcation of
the patient-speciﬁc target locations for LV lead
placement and how they are subtended by the coro-
nary venous tree (Figure 8). This platform was safely
tested in 14 patients with conventional indications for
CRT. It demonstrated that pacing with CMR-derived
segments out of scar had more favorable electric
properties and lower paced QRS duration than pacing
within CMR-derived regions of scar. Also, computed
tomography may be used to systematically evaluate
LV dyssynchrony, myocardial scar, and coronary
venous anatomy in patients undergoing CRT, as
recently shown by Truong et al. (36). These in-
vestigators demonstrated that computed tomo-
graphic wall motion dyssynchrony metrics and
regional mechanical contraction analysis with LV lead
location concordant to regions of maximal wall
thickness were associated with 2-year major adverse
cardiac events but not 6-month CRT response. Of
course, 1 of the major drawbacks of computed
tomography–based evaluation is the signiﬁcant radi-
ation exposure. Indeed, the effective radiation dose
for the retrospective computed tomographic scan was
11.7  5.0 mSv and the total radiation dose for delayed
imaging was 13.5  5.0 mSv. Using the patient’s cor-
onary venous anatomy, scar distribution electro-
physiology, and mechanical contraction pattern to
identify and target the optimal site for the LV lead is a
novel approach to improving CRT effectiveness, thus
representing personalized CRT for the 21st century.
Larger scale, multicenter, randomized clinical trials
will be required to demonstrate whether this
approach yields greater CRT response compared with
the conventional implantation method. Notably,
despite the best-in-class imaging and lead technology
for guiding quadripolar LV lead implantation in a
single procedure (31–35), in about one-third of pa-
tients, a CMR-deﬁned target segment, based on
avoiding scar and targeting mechanical dyssyn-
chrony, could not be achieved. This was because of
the lack of coronary venous anatomy, resulting in
placing the quadripolar LV lead adjacent to or in the
scar. This observation strongly suggests that expect-
ing responses >70% with a conventional transvenous
CRT system in patients presenting mostly with
ischemic etiology represents a utopic goal. As a
consequence, an alternative treatment strategy is
urgently needed; whether this solution would be an
LV percutaneous epicardial approach or LV endocar-
dial pacing remains to be determined. The recent
emergence of LV endocardial stimulation as an
alternative route for the delivery of biventricular
pacing for CRT has growing evidence based on some
data showing superior hemodynamic and electro-
physiological indexes (35–37). The use of novel stra-
tegies that combine electric and mechanical (strain)
assessment may be particularly suitable for an endo-
cardial pacing approach, with the ability to target any
region on the LV endocardial wall without the
constraint of the coronary venous anatomy (38). The
recent development of a wireless intracardiac LV
endocardial electrode for CRT delivery represents a
unique opportunity to use integrated multimodality
image guidance for optimal LV site selection (35).
Finally, recent developments in computer models of
the dyssynchronous heart open new avenues in
assisting physicians to better characterize myocardial
substrate and in qualifying it as amenable to pacing
response as well as to predict the response to pacing
(28,39). A good example of clinically usable computer
model–improved insight in disease mechanism and
diagnosis is that of understanding of septal wall mo-
tion abnormalities, known as septal ﬂash and septal
rebound stretch, in patients with HF referred to CRT
HIGHLIGHTS
 Recent technological advances in cardiac
imaging allow visualization of anatomic
details up to millimeter size in 3D format.
 Electrophysiologists increasingly rely
upon cardiac imaging for diagnosis,
treatment, and management of patients
with various arrhythmic disorders.
 Integration of diagnostic and interven-
tional cardiac imaging will further
increase the effectiveness of cardiac
electrophysiological procedures.
 More extensive use of cardiac imaging
will help in delivering patient-speciﬁc
therapies with ablation and cardiac
implantable electronic devices.
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(Figure 9). The ultimate goal for the application of
modeling for CRT would be to develop a full model of
the heart of an individual patient in a way that does
not disturb clinical workﬂow, to plan the best posi-
tion for the pacing leads, and to test the effect of CRT
ahead of implantation of the device.
CONCLUSIONS
It is clear that device indication, implantation, and
subsequent management have immensely beneﬁted
from the advances in cardiac imaging. In a similar
way, electrophysiology has made signiﬁcant progress
in selecting those patients who may receive the
greatest beneﬁt from cardiac ablation, further
improving the risk/beneﬁt ratio, and more effectively
using health care resources. Undoubtedly, the future
integration of diagnostic and interventional cardiac
imaging will serve the ultimate goal of increasing
effectiveness and efﬁciency of electrophysiological
procedures and interventions as well as to deliver
patient-speciﬁc therapies in cardiac electrophysi-
ology and device indication and implantation.
ADDRESS FOR CORRESPONDENCE: Dr. Angelo
Auricchio, Division of Cardiology, Fondazione Car-
diocentro Ticino, Via Tesserete 48, CH-6977 Lugano,
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